stockrow
Sunday 8 November 2026
Export SVA’s income statement to Excel — free account
Sinovac Biotech, Ltd.
Sinovac Biotech, Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $386.0 million, up 6.82% from fiscal 2024.
6.47
0.00
0.00%
Follow SVA
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 13.59 | 19.77 | 16.18 | 6.05 | 0.07 | 0.08 | 0.19 | 0.19 | 0.19 |
Piotroski F-Score |
2 | 7 | 6 | 4 | 4 | 8 | 3 | 4 | 3 | 3 |
P/S ratio |
4.64 | 1.95 | 1.96 | 2.49 | 1.25 | 0.03 | 0.03 | 0.06 | 0.06 | 0.06 |
Altman Z-Score |
3.11 | 3.78 | 5.31 | 5.60 | 1.80 | 6.24 | 1.93 | 1.61 | 1.70 | 1.22 |
Altman Z″-Score (non-manufacturers) |
3.50 | 5.08 | 8.98 | 8.93 | 5.55 | 18.40 | 16.10 | 12.45 | 11.71 | 8.06 |
P/FCF ratio |
0.00 | 9.63 | 190.99 | 21.56 | 1.82 | 0.04 | 0.05 | 0.14 | 0.00 | 0.00 |
Beneish M-Score |
(1.89) | (2.10) | (1.98) | (1.53) | (2.09) | 29.51 | 1.38 | (2.49) | (2.70) | (2.38) |
P/Operating CF |
47,999.87 | 7.88 | 58.38 | 23.21 | 1.33 | 1.33 | 1.33 | 1.33 | (1.46) | (2.06) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 20 |
P/B ratio |
2.59 | 3.03 | 1.54 | 1.74 | 0.57 | 0.07 | 0.07 | 0.05 | 0.06 | 0.10 |
Price to Tangible BV |
2.59 | 3.03 | 1.54 | 1.74 | 0.57 | 0.07 | 0.07 | 0.05 | 0.06 | 0.10 |
EV/Sales |
4.30 | 1.63 | 1.25 | 1.69 | (0.99) | (0.64) | (0.51) | (1.02) | (0.96) | (0.88) |
EV/EBITDA |
55.92 | 5.59 | 5.70 | 5.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(20.14) | 6.34 | 36.01 | 10.62 | (1.05) | (0.80) | (0.72) | (1.84) | (164.15) | 34.78 |
EV/FCF |
(11.08) | 8.03 | 121.62 | 14.58 | (1.43) | (0.83) | (0.76) | (2.17) | 12.01 | 12.47 |
Quick Ratio |
1.74 | 1.97 | 4.37 | 3.67 | 2.12 | 5.96 | 10.93 | 8.86 | 7.25 | 4.51 |
Current Ratio |
1.97 | 2.20 | 4.88 | 4.01 | 2.30 | 6.18 | 11.11 | 8.97 | 7.33 | 4.59 |
Net Debt/EBITDA |
(4.44) | (1.52) | (3.25) | (2.72) | (5.21) | (0.76) | 36.34 | 19.39 | 24.96 | 15.70 |
Debt/Assets |
19.27% | 13.39% | 3.76% | 1.63% | 2.17% | 0.12% | 0.08% | 1.87% | 3.05% | 5.79% |
Debt/Equity |
0.31 | 0.23 | 0.05 | 0.02 | 0.04 | 0.00 | 0.00 | 0.02 | 0.04 | 0.08 |
Asset Turnover |
0.35 | 0.68 | 0.69 | 0.60 | 0.43 | 2.08 | 0.10 | 0.03 | 0.03 | 0.04 |
Operating CF/Net income |
25.94 | 2.32 | 0.36 | 0.98 | 4.59 | 1.81 | (7.14) | (10.28) | (0.63) | 8.58 |
Capex/Depreciation |
(2.49) | (2.56) | (1.14) | (2.32) | (33.60) | (8.51) | (2.60) | (0.99) | (0.88) | (0.49) |
Interest Coverage |
0.29 | 28.95 | 42.35 | 105.48 | 148.41 | 6,189.44 | (368.72) | (144.50) | (89.68) | (49.92) |
| (0.45%) | 16.82% | 9.29% | 12.36% | 14.18% | 112.85% | 0.81% | (0.11%) | 0.83% | (0.72%) | |
| (0.29%) | 10.11% | 6.51% | 9.68% | 8.87% | 90.74% | 0.70% | (0.10%) | 0.70% | (0.57%) | |
ROIC |
0.30% | 28.04% | 22.00% | 27.93% | 0.00% | 2,332.85% | (20.75%) | (51.13%) | (69.65%) | (121.75%) |
Return on Tangible Assets |
(0.45%) | 13.74% | 7.34% | 11.82% | 9.65% | 63.12% | 0.90% | (0.12%) | 0.90% | (0.96%) |
Average Days of Receivables |
251.12 | 138.60 | 123.12 | 168.72 | 181.20 | 17.94 | 149.03 | 329.89 | 319.50 | 296.04 |
Research and Development Expense of Revenue |
17.46% | 11.75% | 9.54% | 9.86% | 9.55% | 0.80% | 29.62% | 74.48% | 74.90% | 56.00% |
Selling, General and Administrative Expense of Revenue |
57.96% | 50.11% | 59.66% | 49.37% | 34.57% | 3.05% | 55.17% | 127.24% | 116.48% | 86.26% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
3.33% | 0.56% | 1.87% | 1.22% | 2.00% | 0.04% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.15 | 0.19 | 0.46 | 0.41 | 1.22 | 18.83 | 16.77 | 16.07 | 15.25 | 7.40 |
Graham Number |
0.00 | 5.93 | 5.97 | 5.78 | 16.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(0.17%) | 7.36% | 5.06% | 6.18% | 16.54% | 1,335.39% | 1,324.11% | 531.22% | 531.22% | 531.22% |
Free Cash Flow Yield |
(8.36%) | 10.39% | 0.52% | 4.64% | 54.99% | 2,389.78% | 2,171.52% | 735.81% | (125.26%) | (110.90%) |
Revenue per Share |
1.27 | 3.06 | 3.55 | 2.59 | 5.16 | 195.09 | 15.00 | 6.55 | 5.03 | 5.37 |
Operating CF per Share |
(0.27) | 1.05 | 0.12 | 0.41 | 4.85 | 154.59 | (7.75) | 1.93 | (0.79) | (7.13) |
Capex per Share |
(0.22) | (0.21) | (0.09) | (0.11) | (1.29) | (7.25) | (4.05) | (2.17) | (1.36) | (0.68) |
Free Cash Flow per Share |
(0.49) | 0.84 | 0.04 | 0.30 | 3.56 | 147.34 | (11.79) | (0.24) | (2.15) | (7.81) |
Cash per Share |
1.15 | 2.03 | 2.74 | 2.17 | 11.99 | 135.19 | 113.78 | 153.47 | 142.16 | 92.39 |
Shareholders Equity per Share |
2.28 | 3.11 | 4.51 | 3.71 | 11.33 | 139.72 | 127.76 | 162.08 | 143.24 | 89.01 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.28 | 3.11 | 4.51 | 3.71 | 11.33 | 139.72 | 127.76 | 162.08 | 143.24 | 89.01 |
Free Cash Flow |
(28.09) | 47.86 | 2.35 | 28.47 | 351.68 | 14,632.74 | (1,173.50) | (17.51) | (154.32) | (560.89) |
Working Capital |
64.48 | 111.35 | 225.97 | 262.41 | 880.68 | 12,502.26 | 11,034.77 | 10,304.59 | 9,192.61 | 5,524.13 |
Capital Expenditures |
(12.63) | (11.90) | (5.59) | (10.61) | (127.63) | (719.80) | (402.76) | (156.15) | (97.43) | (48.71) |
Net Current Asset Value |
49.06 | 81.81 | 206.32 | 249.50 | 779.09 | 12,042.95 | 10,724.49 | 9,627.76 | 8,600.66 | 4,919.03 |
EV/EBIT |
617.63 | 756.23 | 6.31 | 6.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.17 | 0.07 | 0.02 | 0.04 | 0.25 | 0.04 | 0.27 | 0.33 | 0.27 | 0.13 |
Price to Operating Income |
666.66 | 907.02 | 9.91 | 8.95 | 2.97 | 2.97 | 2.97 | 2.97 | 2.97 | 2.97 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.08 | 0.06 | 0.07 | 0.06 | 0.02 | 0.09 | 0.16 | 0.17 | 0.13 | 0.14 |
Cash ROIC |
(11.91%) | 14.36% | 0.49% | 5.03% | 14.99% | 53.56% | (4.88%) | (0.08%) | (0.74%) | (4.15%) |
Accounts Receivable Turnover |
1.63 | 3.01 | 3.20 | 2.57 | 2.78 | 32.13 | 1.91 | 0.91 | 0.98 | 1.23 |
Accounts Payable Turnover |
0.94 | 0.48 | 0.45 | 0.60 | 0.50 | 1.74 | 0.71 | 0.16 | 0.16 | 0.18 |
Inventory Turnover |
1.37 | 1.20 | 1.11 | 1.23 | 1.01 | 4.46 | 2.46 | 0.93 | 1.21 | 1.30 |
Average Days of Payables |
406.84 | 1,071.52 | 738.05 | 662.01 | 1,148.72 | 347.44 | 483.10 | 2,458.75 | 2,083.29 | 1,779.43 |
Days of Inventory on Hand |
229.86 | 353.78 | 370.43 | 313.03 | 574.90 | 127.83 | 96.37 | 337.05 | 251.45 | 277.53 |
Average Receivables |
44.43 | 58.02 | 71.83 | 95.60 | 183.61 | 602.94 | 780.95 | 517.22 | 370.64 | 314.71 |
Average Payables |
23.81 | 42.19 | 54.70 | 54.44 | 135.16 | 616.04 | 963.29 | 947.58 | 896.12 | 703.84 |
Average Inventory |
16.38 | 16.86 | 22.35 | 26.47 | 66.83 | 240.66 | 278.12 | 158.16 | 116.26 | 95.61 |
Average Assets |
207.14 | 255.29 | 334.50 | 411.04 | 1,176.81 | 9,324.75 | 15,431.37 | 13,863.30 | 12,974.65 | 10,439.50 |
Average Common Equity |
133.09 | 153.40 | 234.53 | 322.05 | 736.15 | 7,498.05 | 13,294.32 | 12,177.56 | 10,967.95 | 8,344.84 |
Columns are period end dates · fundamentals updated 26 Oct 2026